Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chronic inflammatory skin disorders are caused by immune system problems, not just skin issues.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.